SUKHATME MAYUKH (Pres &Chief Investment Officer) sold 1.7% of their position (339.44K shares) of ROIVANT SCIENCES LTD. on the open market
Open‑market sale worth $8.99M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/11/2026ACC: 0001635088-26-000015
Officer· Pres &Chief Investment Officer
Since Oct 2021
-651.56K
Net shares
Net seller
$17.25M
Total sold
1
Open market trades
0B · 1S
4
Total transactions
651.56K acquired · 1.30M disposed
Non-Derivative Transactions3
Common Shares
Direct
Shares
+651.56K
Price / share
$12.68
Trade value
$8.26M
% of position
3.5%
2/9/2026
18.84M→19.49M
Common Shares
Direct
Shares
−339.44K
Price / share
$26.47
Trade value
$8.99M
% of position
1.7%
2/9/2026
19.49M→19.15M
Common Shares
Direct
Shares
−312.12K
Price / share
$26.47
Trade value
$8.26M
% of position
1.6%
2/9/2026
19.15M→18.84M
Total
Net shares
+0.00
Net value
-$8.98M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/9/2026 | M · Option Exercise | +651.56K | $12.68 | $8.26M | 3.5% | 18.84M | 19.49M |
| Common Shares Direct | 2/9/2026 | S · Sale | −339.44K | $26.47 | $8.99M | 1.7% | 19.49M | 19.15M |
| Common Shares Direct | 2/9/2026 | J · J | −312.12K | $26.47 | $8.26M | 1.6% | 19.15M | 18.84M |
| Total | +0.00 | -$8.98M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
651.56K shares
Shares
−651.56K
Strike price
12.68
Held after
0.00
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares651.56K shares | 2/9/2026 | M · Option Exercise | −651.56K | 12.68 | — | 0.00 |